SCHEMBL7425317

SCHEMBL7425317

CC(=O)C=Cc1cn(Cc2ccccc2Cl)c2cc(C(=O)O)ccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 7/20 0.49
MAPT P10636 4/20 0.46
LMNA P02545 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
PDE4A P27815 3/20 0.43
PDE4B Q07343 3/20 0.43
PDE4C Q08493 3/20 0.43
PDE4D Q08499 3/20 0.43
SENP7 Q9BQF6 2/20 0.41
CNR2 P34972 1/20 0.41
ATM Q13315 1/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
CASP3 P42574 1/20 0.41
RECQL P46063 1/20 0.41
RAB9A P51151 1/20 0.41
GFER P55789 1/20 0.41
SENP8 Q96LD8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7471953 1.00 SLC22A12 (0.49) SLC22A12MAPTLMNAMEN1KMT2A
SCHEMBL7419442 0.91 MAPT (0.48) SLC22A12MAPTLMNAMEN1KMT2A
SCHEMBL7470357 0.91 MAPT (0.48) SLC22A12MAPTLMNAMEN1KMT2A
SCHEMBL7425520 0.90 MAPT (0.52) SLC22A12MAPTLMNAMEN1KMT2A
SCHEMBL7470611 0.90 MAPT (0.52) SLC22A12MAPTLMNAMEN1KMT2A
SCHEMBL7427340 0.86 SMN1; SMN2 (0.54) SLC22A12MAPTLMNAMEN1KMT2A
SCHEMBL7418115 0.78 SLC22A12 (0.52) SLC22A12MAPTLMNAMEN1KMT2A
SCHEMBL1995112 0.77 GAA (0.53) SLC22A12MAPTLMNAMEN1KMT2A
SCHEMBL7422870 0.77 MAPT (0.55) SLC22A12MAPTLMNAMEN1KMT2A
SCHEMBL7421449 0.76 SMN1; SMN2 (0.56) SLC22A12MAPTLMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed